In March 2025, the company introduced new plans for your immediate-to-client offering of its Wegovy weight loss drug. The company founded a different pharmacy, termed NovoCare, which would charge customers $499 each month for access to the drug, under fifty percent the cost of the drug by means of other pharmaceutical distribution networks.[fifty t